2387505-59-9

2387505-59-9 structure
2387505-59-9 structure
  • Name: AP14145 hydrochloride
  • Chemical Name: AP14145 hydrochloride
  • CAS Number: 2387505-59-9
  • Molecular Formula: C18H18ClF3N4O
  • Molecular Weight: 398.81
  • Catalog: Signaling Pathways Membrane Transporter/Ion Channel Potassium Channel
  • Create Date: 2020-08-11 18:01:45
  • Modify Date: 2024-01-10 18:14:12
  • AP14145 hydrochloride is a potent KCa2 (SK) channel negative allosteric modulator with an IC50 of 1.1 μM for KCa2.2 (SK2) and KCa2.3 (SK3) channels. AP14145 hydrochloride inhibition strongly depends on two amino acids, S508 and A533 in the channel. AP14145 hydrochloride prolonged atrial effective refractory period (AERP) in rats and demonstrates antiarrhythmic effects in a Vernakalant-resistant porcine model of atrial fibrillation (AF)[1][2].

Name AP14145 hydrochloride
Description AP14145 hydrochloride is a potent KCa2 (SK) channel negative allosteric modulator with an IC50 of 1.1 μM for KCa2.2 (SK2) and KCa2.3 (SK3) channels. AP14145 hydrochloride inhibition strongly depends on two amino acids, S508 and A533 in the channel. AP14145 hydrochloride prolonged atrial effective refractory period (AERP) in rats and demonstrates antiarrhythmic effects in a Vernakalant-resistant porcine model of atrial fibrillation (AF)[1][2].
Related Catalog
Target

IC50: 1.1 μM (KCa2.2) and 1.1 μM (KCa2.3)[1]

In Vitro AP14145 (10 nM-30 μM) inhibits both hKCa2.2 and hKCa2.3 channel currents in a concentration‐dependent fashion. AP14145 (10 μM) inhibits 50% of the hKCa1.1 current, 90% of the hKCa2.1 current and has no effect on hKCa3.1 channel. AP14145 (10 μM) increases the EC50 of Ca2+ on KCa2.3 channels from 0.36 to 1.2 μM[1]. AP14145 hydrochloride demonstrates an IC50 in whole-cell patch clamp on the human SK3 channel of 1.3 µM. AP14145 inhibits hERG (KV11.1) with an IC50 of 71.8 µM and Kir3.1/Kir3.4 (IKACh) with an IC50 of 9.3 µM and does not produce any significant effects on KV1.5 (IKur), KV7.1/KCNE1 (IKs), KV4.3/KChiP2 (Ito), and Kir2.1 (IK1) in 30 µM or on NaV1.5 (15 µM; INa) on a panel of cardiac ion channels. AP14145 (1-10 µM) produces no significant block of CaV1.2[2].
In Vivo AP14145 (10 μM) increases the duration of the atrial effective refractory period (AERP) in isolated perfused rat hearts[1]. AP14145 (2.5 and 5 mg/kg; bolus injections (iv)) increases the duration of the atrial effective refractory period in male sprague-dawley rats (250-350 g, 1-3 months old)[1]. AP14145 (5 mg/kg; bolus injections) has a Cmax of 8355 nmol/L, a t½ of 24.3 minutes in landrace pigs (12-13 weeks old, 30-35 kg gilts)[2].
References

[1]. Rafel Simó-Vicens, et al. A New Negative Allosteric Modulator, AP14145, for the Study of Small Conductance Calcium-Activated Potassium (KCa2) Channels. Br J Pharmacol. 2017 Dec;174(23):4396-4408.

[2]. Jonas Goldin Diness, et al. Termination of Vernakalant-Resistant Atrial Fibrillation by Inhibition of Small-Conductance Ca2+-Activated K + Channels in Pigs. Circ Arrhythm Electrophysiol. 2017 Oct;10(10):e005125.

Molecular Formula C18H18ClF3N4O
Molecular Weight 398.81
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.